A 27-year-old woman from Sergipe has received a groundbreaking treatment involving polylaminin, which may restore movement to individuals with paraplegia or quadriplegia.
A 27-year-old woman from the state of Sergipe, Brazil, has undergone an innovative treatment with polylaminin, a substance that aims to reconnect the spinal cord and potentially restore movement to those afflicted with paraplegia or quadriplegia. This information was shared by José Calasans, the neuro-surgery coordinator at the Hospital Unimed in Aracaju, meanwhile confirming that the treatment was administered this past Sunday, February 22, during a special procedure conducted by a team from Rio de Janeiro.
The patient has a diagnosis of limb paraplegia, which restricts her leg movement. Calasans noted that she has previously undergone a surgical procedure in December 2025, which involved decompression and arthrodesis to stabilize the spine with screws and rods. This latest treatment with polylaminin is a new frontier in spinal therapies, highlighting medical advancements in addressing severe mobility impairments and potentially altering the prognosis for many patients with similar conditions.
Polylaminin, developed in a laboratory, mimics laminin—a protein naturally produced in human bodies, pivotal during embryonic development. Its usage in this context not only marks a significant improvement in neuroscience but also offers hope for increased functionality and quality of life for individuals facing such debilitating challenges due to spinal injuries or congenital conditions.
